Olivier Litzka

Insider Reports History

Entity
Individual
Location
C/O Mineralys Therapeutics, Inc., 150 N. Radnor Chester Rd, Ste. F200, Radnor, PA
Signature
/s/ Adam Levy, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivier Litzka:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. Director Stock Option 22K May 22, 2024 Direct

Insider Reports Filed by Olivier Litzka

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MLYS Mineralys Therapeutics, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director
MLYS Mineralys Therapeutics, Inc. Apr 27, 2023 1 $0 4 May 1, 2023 Director
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 0 $0 3 Feb 9, 2023 Director